Free Trial
LON:BXP

Beximco Pharmaceuticals (BXP) Share Price, News & Analysis

GBX 40
+1.50 (+3.90%)
(As of 07:06 AM ET)
Today's Range
38.50
40
50-Day Range
37.45
41
52-Week Range
33.56
45
Volume
5,997 shs
Average Volume
54,268 shs
Market Capitalization
£178.44 million
P/E Ratio
500.00
Dividend Yield
7.50%
Price Target
N/A
BXP stock logo

About Beximco Pharmaceuticals Stock (LON:BXP)

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

BXP Stock Price History

BXP Stock News Headlines

Beximco Pharma Share Chat
Beximco Pharmaceuticals Ltd DR
Kiss of death from Joe Biden
I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.
Beximco Pharmaceuticals Ltd. (BXPq)
BXP.L - Beximco Pharmaceuticals Limited
Beximco Pharmaceuticals
Beximco Pharmaceuticals Ltd.
Kiss of death from Joe Biden
I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.
Beximco Pharmaceuticals Ltd (BXPH)
Beximco Pharmaceuticals Ltd. GDR
See More Headlines
Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Trading
CIK
N/A
Fax
N/A
Employees
780
Year Founded
N/A

Profitability

Net Income
£5.33 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£43.08 billion

Miscellaneous

Free Float
N/A
Market Cap
£171.75 million
Optionable
Not Optionable
Beta
0.63
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Mohammad Ali Nawaz
    Chief Financial Officer
  • Mr. S. M. Rabbur Reza
    Chief Operating Officer
  • Mr. Jamal Ahmed Choudhury
    Director of Accounts & Finance
  • Mr. Rizvi Ul Kabir
    Director of Marketing
  • Mr. M. A. Arshad Bhuiyan
    General Manager of Human Resources
  • Mr. Zakaria Seraj Chowdhury
    Head of Distribution Services & Director of International Marketing
  • Mr. Mohammad Asad Ullah FCS
    Company Secretary & Executive Director

BXP Stock Analysis - Frequently Asked Questions

How have BXP shares performed this year?

Beximco Pharmaceuticals' stock was trading at GBX 41.50 at the beginning of the year. Since then, BXP shares have decreased by 3.6% and is now trading at GBX 40.
View the best growth stocks for 2024 here
.

How do I buy shares of Beximco Pharmaceuticals?

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:BXP) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners